176
Participants
Start Date
February 28, 2017
Primary Completion Date
November 14, 2017
Study Completion Date
February 12, 2018
Dupilumab
Administration of dose of Dupilumab as per protocol by auto-injector or prefilled syringe
Auto-injector Device
Delivery of Dupilumab by auto-injector device
Prefilled syringe
Delivery of Dupilumab by prefilled syringe
Regeneron Investigational Site, New York
Regeneron Investigational Site, Forest Hills
Regeneron Investigational Site, Corning
Regeneron Investigational Site, Rockville
Regeneron Investigational Site, Norfolk
Regeneron Investigational Site, High Point
Regeneron Investigational Site, Raleigh
Regeneron Investigational Site, Charleston
Regeneron Investigational Site, Greer
Regeneron Investigational Site, Tampa
Regeneron Investigational Site, Coral Gables
Regeneron Investigational Site, Birmingham
Regeneron Investigational Site, Birmingham
Regeneron Investigational Site, Indianapolis
Regeneron Investigational Site, Plymouth
Regeneron Investigational Site, Skokie
Regeneron Investigational Site, Normal
Regeneron Investigational Site, Saint Joseph
Regeneron Investigational Site, Fort Smith
Regeneron Investigational Site, Tulsa
Regeneron Investigational Site, Fort Worth
Regeneron Investigational Site, Bellaire
Regeneron Investigational Site, Webster
Regeneron Investigational Site, San Antonio
Regeneron Investigational Site, San Antonio
Regeneron Investigational Site, Denver
Regeneron Investigational Site, Los Angeles
Regeneron Investigational Site, Rolling Hills Estates
Regeneron Investigational Site, Santa Monica
Regeneron Investigational Site, Long Beach
Regeneron Investigational Site, Oceanside
Regeneron Investigational Site, Murrieta
Regeneron Investigational Site, Orange
Regeneron Investigational Site, Portland
Regeneron Investigational Site, Tacoma
Regeneron Investigational Site, Berlin
Regeneron Investigational Site, Windsor
Collaborators (1)
Sanofi
INDUSTRY
Regeneron Pharmaceuticals
INDUSTRY